Literature DB >> 16751421

NK cells and gamma delta+ T cells are phenotypically and functionally defective due to preferential apoptosis in patients with atopic dermatitis.

Michie Katsuta1, Yukio Takigawa, Momoko Kimishima, Miyuki Inaoka, Ryo Takahashi, Tetsuo Shiohara.   

Abstract

Innate immune cells mediate a first line of defense against pathogens and determine the nature of subsequent acquired immune responses, mainly by producing profound amounts of cytokines. Given these diverse tasks, it is predictable that defective NK and gammadelta(+) T cell responses could be the underlying mechanism for the immunological alterations observed in atopic dermatitis (AD). Indeed, the frequencies of circulating NK cells and gammadelta(+) T cells were profoundly reduced in AD patients. They also displayed a defective ability to sustain TNF-alpha and IFN-gamma, but not IL-4, production after in vitro stimulation, and the defect was restricted to innate immune cells. Surprisingly, on the depletion of CD14(+) monocytes, this selective impairment of TNF-alpha and IFN-gamma production was restored to levels comparable to that observed in controls. Release of IL-10 from monocytes was not a major mechanism of the NK and gammadelta(+) T cell dysfunction. Apoptosis as revealed by annexin V binding, was preferentially observed in NK and gammadelta(+) T cells from AD patients when stimulated in the presence of monocytes, and depletion of monocytes significantly protected these cells from apoptotic cell death. Preferential apoptosis of NK cells by activated monocytes in AD patients was cell-contact-dependent. These results indicate that, once NK and gammadelta(+) T cells in AD patients are in immediate contact with activated monocytes, these cells are specifically targeted for apoptosis, leading to the reduced type 1 cytokine production, thereby directing subsequent acquired immune responses toward a type-2 pattern and increasing susceptibility to infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16751421     DOI: 10.4049/jimmunol.176.12.7736

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

Review 1.  Quantitative peripheral blood perturbations of γδ T cells in human disease and their clinical implications.

Authors:  Ilan Bank; Victoria Marcu-Malina
Journal:  Clin Rev Allergy Immunol       Date:  2014-12       Impact factor: 8.667

2.  Research on stress-induced apoptosis of natural killer cells and the alteration of their killing activity in mouse liver.

Authors:  Zhen Ma; Yang Liu; Xin Zhou; Hai-Long Yu; Ming-Qi Li; Chikako Tomiyama-Miyaji; Toru Abo; Xue-Feng Bai
Journal:  World J Gastroenterol       Date:  2013-10-07       Impact factor: 5.742

3.  Blood natural killer cell deficiency reveals an immunotherapy strategy for atopic dermatitis.

Authors:  Madison R Mack; Jonathan R Brestoff; Melissa M Berrien-Elliott; Anna M Trier; Ting-Lin B Yang; Matthew McCullen; Patrick L Collins; Haixia Niu; Nancy D Bodet; Julia A Wagner; Eugene Park; Amy Z Xu; Fang Wang; Rebecca Chibnall; M Laurin Council; Carrie Heffington; Friederike Kreisel; David J Margolis; David Sheinbein; Paola Lovato; Eric Vivier; Marina Cella; Marco Colonna; Wayne M Yokoyama; Eugene M Oltz; Todd A Fehniger; Brian S Kim
Journal:  Sci Transl Med       Date:  2020-02-26       Impact factor: 17.956

4.  Defective natural killer cell activity in a mouse model of eczema herpeticum.

Authors:  Yuko Kawakami; Tomoaki Ando; Jong-Rok Lee; Gisen Kim; Yu Kawakami; Tae Nakasaki; Manando Nakasaki; Kenji Matsumoto; Youn Soo Choi; Toshiaki Kawakami
Journal:  J Allergy Clin Immunol       Date:  2016-07-29       Impact factor: 10.793

5.  Mechanistic studies of a peptidic GRP78 ligand for cancer cell-specific drug delivery.

Authors:  Ying Liu; Sebastian C J Steiniger; YoungSoo Kim; Gunnar F Kaufmann; Brunhilde Felding-Habermann; Kim D Janda
Journal:  Mol Pharm       Date:  2007-03-21       Impact factor: 4.939

6.  IL-17 constrains natural killer cell activity by restraining IL-15-driven cell maturation via SOCS3.

Authors:  Xuefu Wang; Rui Sun; Xiaolei Hao; Zhe-Xiong Lian; Haiming Wei; Zhigang Tian
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-12       Impact factor: 11.205

7.  Skin- and gut-homing molecules on human circulating γδ T cells and their dysregulation in inflammatory bowel disease.

Authors:  E R Mann; N E McCarthy; S T C Peake; A N Milestone; H O Al-Hassi; D Bernardo; C T Tee; J Landy; M C Pitcher; S A Cochrane; A L Hart; A J Stagg; S C Knight
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

Review 8.  Response of gammadelta T Cells to plant-derived tannins.

Authors:  Jeff Holderness; Jodi F Hedges; Katie Daughenbaugh; Emily Kimmel; Jill Graff; Brett Freedman; Mark A Jutila
Journal:  Crit Rev Immunol       Date:  2008       Impact factor: 2.214

9.  Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum.

Authors:  Yuko Kawakami; Yoshiaki Tomimori; Kenji Yumoto; Shunji Hasegawa; Tomoaki Ando; Yutaka Tagaya; Shane Crotty; Toshiaki Kawakami
Journal:  J Exp Med       Date:  2009-05-25       Impact factor: 14.307

Review 10.  Current aspects of innate and adaptive immunity in atopic dermatitis.

Authors:  Andreas Wollenberg; Elisabeth Klein
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 10.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.